Literature DB >> 6211771

ELISA antibodies to cysticerci of Taenia solium in human populations in New Guinea, Oceania, and Southeast Asia.

M R Coker-Vann, D B Subianto, P Brown, A R Diwan, R Desowitz, R M Garruto, C J Gibbs, D C Gajdusek.   

Abstract

The presence of ELISA antibodies to cysticerci of Taenia solium was surveyed in populations of New Guinea, Micronesia, and several areas of Southeast Asia. It is confirmed that cysticercosis in New Guinea remains limited to the primary Wissel Lakes focus in Irian Jaya, where the disease was introduced by the importation of infected pigs, and that it has not spread to populations east or south of the Wissel Lakes, or to Papua New Guinea. On the island of Bali, Indonesia, 21% of sera were positive from one village where pigs are especially numerous, whereas in Sumatra, Indonesia, only 3%-4% of sera were positive. In Singapore, there was a higher proportion of positive sera among the Chinese (13%) than among the Indian (5%) or Malay (3%) Moslems. From 3 to 13% of sera from populations in Micronesia, Burma, Vietnam, and the Philippines were also found to react with cysticercus antigen. However, the problem of incomplete ELISA specificity raises the possibility that in areas not known to be endemic for T. solium, seropositive results could represent either subclinical infection with cysticerci or crossreactivity to other parasitic infections.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6211771

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  7 in total

1.  Screening for intestinal parasitic infections among Myanmar migrant workers in Thai food industry: a high-risk transmission.

Authors:  Surang Nuchprayoon; Vivornpun Sanprasert; Sakchai Kaewzaithim; Wilai Saksirisampant
Journal:  J Immigr Minor Health       Date:  2008-09-25

Review 2.  Proposed diagnostic criteria for neurocysticercosis.

Authors:  O H Del Brutto; V Rajshekhar; A C White; V C Tsang; T E Nash; O M Takayanagui; P M Schantz; C A Evans; A Flisser; D Correa; D Botero; J C Allan; E Sarti; A E Gonzalez; R H Gilman; H H García
Journal:  Neurology       Date:  2001-07-24       Impact factor: 9.910

Review 3.  Management of neurocysticercosis.

Authors:  Terrence Riley; A C White
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

4.  Multiple brain parenchymal neurocysticercosis with extraocular muscle cysticercosis affecting levator palpebral superioris and superior rectus complex: an unusual association.

Authors:  Rajesh Verma; Anupam Jaiswal
Journal:  BMJ Case Rep       Date:  2013-01-25

5.  Characterization by enzyme-linked immunosorbent assay of the humoral immune response in patients with neurocysticercosis and its application in immunodiagnosis.

Authors:  B Espinoza; G Ruiz-Palacios; A Tovar; M A Sandoval; A Plancarte; A Flisser
Journal:  J Clin Microbiol       Date:  1986-10       Impact factor: 5.948

Review 6.  Immunological and molecular diagnosis of cysticercosis.

Authors:  Silvia Rodriguez; Patricia Wilkins; Pierre Dorny
Journal:  Pathog Glob Health       Date:  2012-09       Impact factor: 2.894

Review 7.  The present situation and towards the prevention and control of neurocysticercosis on the tropical island, Bali, Indonesia.

Authors:  Toni Wandra; Kadek Swastika; Nyoman S Dharmawan; Ivan Elisabeth Purba; I Made Sudarmaja; Takahiko Yoshida; Yasuhito Sako; Munehiro Okamoto; Ni Luh Putu Eka Diarthini; Dewa Ayu Agus Sri Laksemi; Tetsuya Yanagida; Minoru Nakao; Akira Ito
Journal:  Parasit Vectors       Date:  2015-03-07       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.